Consideration of a Credibility Assessment Framework in Model‐Informed Drug Development: Potential Application to Physiologically‐Based Pharmacokinetic Modeling and Simulation
The use of computational models in drug development has grown during the past decade. These model‐informed drug development (MIDD) approaches can inform a variety of drug development and regulatory decisions. When used for regulatory decision making, it is important to establish that the model is cr...
Saved in:
Main Authors: | Colleen Kuemmel (Author), Yuching Yang (Author), Xinyuan Zhang (Author), Jeffry Florian (Author), Hao Zhu (Author), Million Tegenge (Author), Shiew‐Mei Huang (Author), Yaning Wang (Author), Tina Morrison (Author), Issam Zineh (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of best practices in physiologically based pharmacokinetic modeling to support clinical pharmacology regulatory decision‐making-A workshop summary
by: Daphney Jean, et al.
Published: (2021) -
Anti-SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology Considerations
by: Xinyuan Zhang, et al.
Published: (2021) -
Current Scientific Considerations to Verify Physiologically‐Based Pharmacokinetic Models and Their Implications for Locally Acting Products
by: Liang Zhao, et al.
Published: (2019) -
A Comprehensive Framework for Physiologically‐Based Pharmacokinetic Modeling in Matlab
by: Felix Stader, et al.
Published: (2019) -
Opportunities and challenges for applying model‐informed drug development approaches to gene therapies
by: Artur Belov, et al.
Published: (2021)